PAROLINI, CINZIA
 Distribuzione geografica
Continente #
EU - Europa 8.848
AS - Asia 7.222
NA - Nord America 6.390
SA - Sud America 707
AF - Africa 135
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.336
Nazione #
US - Stati Uniti d'America 6.193
GB - Regno Unito 2.618
CN - Cina 2.427
SG - Singapore 2.089
DE - Germania 1.954
IT - Italia 1.508
SE - Svezia 681
RU - Federazione Russa 598
HK - Hong Kong 575
BR - Brasile 546
VN - Vietnam 494
BD - Bangladesh 384
FR - Francia 350
IN - India 336
TR - Turchia 232
IE - Irlanda 223
KR - Corea 218
NL - Olanda 184
FI - Finlandia 181
UA - Ucraina 154
ID - Indonesia 113
CA - Canada 105
JP - Giappone 103
GR - Grecia 74
EU - Europa 71
ES - Italia 65
CO - Colombia 56
MX - Messico 52
DK - Danimarca 51
PL - Polonia 51
IQ - Iraq 45
AR - Argentina 40
TW - Taiwan 34
CI - Costa d'Avorio 32
AU - Australia 26
BE - Belgio 23
PK - Pakistan 23
AT - Austria 20
UZ - Uzbekistan 20
CH - Svizzera 19
ZA - Sudafrica 19
PT - Portogallo 17
MA - Marocco 16
PH - Filippine 16
SA - Arabia Saudita 16
MY - Malesia 15
VE - Venezuela 15
EC - Ecuador 14
KE - Kenya 13
CL - Cile 12
JO - Giordania 12
AE - Emirati Arabi Uniti 11
EG - Egitto 10
RO - Romania 10
TN - Tunisia 10
BA - Bosnia-Erzegovina 9
PE - Perù 9
IR - Iran 8
LT - Lituania 8
OM - Oman 8
SC - Seychelles 8
BO - Bolivia 7
RS - Serbia 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
GT - Guatemala 6
JM - Giamaica 6
NP - Nepal 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
NO - Norvegia 5
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
HU - Ungheria 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
PA - Panama 4
PY - Paraguay 4
SN - Senegal 4
UY - Uruguay 4
AL - Albania 3
ET - Etiopia 3
IL - Israele 3
MT - Malta 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TH - Thailandia 3
AO - Angola 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GH - Ghana 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MZ - Mozambico 2
NG - Nigeria 2
PR - Porto Rico 2
Totale 23.374
Città #
Southend 2.438
Singapore 1.224
Hanover 1.048
Ashburn 701
Milan 564
Hong Kong 526
Chandler 410
Beijing 407
San Jose 393
Seattle 329
Princeton 307
Frankfurt am Main 286
Dallas 242
Council Bluffs 231
Dublin 215
Wilmington 213
Fairfield 187
Los Angeles 177
Ann Arbor 167
Santa Clara 159
Nanjing 148
Ho Chi Minh City 137
Dearborn 132
Lauterbourg 131
Grafing 125
Shanghai 122
Bengaluru 119
New York 116
Woodbridge 109
Houston 106
Guangzhou 105
Hefei 105
Hanoi 103
Boardman 102
Redwood City 90
Des Moines 86
Redmond 85
Moscow 84
Jacksonville 81
Buffalo 78
Helsinki 76
Cambridge 75
Jinan 68
Shenyang 66
Jakarta 62
Tianjin 61
Mountain View 59
Rome 57
Somerville 57
Sakarya 55
Cangzhou 54
Changsha 53
São Paulo 52
Seoul 50
Bühl 47
Tokyo 47
Athens 46
Andover 44
Munich 44
Hangzhou 41
Serra 41
Bogotá 40
Hebei 40
Fuzhou 36
Eitensheim 35
Chicago 33
Abidjan 32
Hamburg 31
Nanchang 31
Roxbury 31
Warsaw 30
Berlin 29
Dong Ket 29
Phoenix 28
Toronto 28
Haiphong 27
The Dalles 27
Turin 27
Columbus 26
Shenzhen 26
Da Nang 25
Quanzhou 25
Zhengzhou 24
Ankara 21
Rio de Janeiro 20
Atlanta 19
Brussels 19
Mumbai 19
Paris 19
San Diego 19
Washington 18
Istanbul 16
Tashkent 16
Wuhan 16
Brasília 15
Fremont 15
Kunming 15
Kyoto 15
Naples 15
Nuremberg 15
Totale 14.495
Nome #
The mutual interplay of gut microbiota, diet and human disease 704
Lipid phosphate phosphatase 3 in vascular pathophysiology 513
Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation 430
Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein E knockout mice by the blood-pool contrast agent B22956/1 419
High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology : A structural and ultrastructural study 392
Interazione tra gli acidi biliari e il microbiota intestinale: implicazioni fisiopatologiche = Reciprocal interactions between bile acids and intestinal microbiota: pathophysiological implications 387
Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids 382
Il trattamento con topiramato protegge i topi APOE-KO dall’insorgenza di danno renale senza modificare i livelli dei lipidi plasmatici 356
Acute effect of Tetranectin-ApoA-I infusion on atherosclerosis progression/regression in hypercholesterolemic rabbits 349
Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model 339
Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats 329
Cholesterol accumulation and inflammation in skin and skin-draining lymph nodes in ApoE-KO mice lacking murine ApoA-I 297
A single infusion of trimeric apoA-I in hypercholesterolemic rabbits stabilizes atherosclerotic plaques and increases plasma cholesterol efflux capacity 297
An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasma Cholesterol-Lowering Activity in apoE(-/-) Mice 292
L-homoarginine administration reduces neointimal hyperplasia in balloon-injured rat carotids 281
Liver-specific deletion of the PPAP2B gene worsens atherosclerosis in apoE-/- mice 281
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic Rabbits 271
Beta2-adrenergic activity modulates vascular tone regulation in lecithin : cholesterol acyltransferase knockout mice 270
Homoarginine administration reduces neointimal hyperplasia in a rat model of carotid artery balloon injury 268
Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion 267
Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE -/- mice 253
A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in apoE-deficient mice 252
Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits 247
Cholesterol-lowering effect of dietary Lupinus angustifolius proteins in adult rats through regulation of genes involved in cholesterol homeostasis 233
Apolipoprotein A-I and the molecular variant apoA-I Milano : evaluation of the antiatherogenic effects in a knock-in mouse model 218
Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury 215
Inhibition of isoprenoid biosynthesis and arterial smooth muscle cell proliferation 211
Il trattamento con fenretinide peggiora l’aterosclerosi nonostante effetti metabolici favorevoli 210
Nutraceuticals and bioactive components from fish for dyslipidemia and cardiovascular risk reduction 208
Evaluation of a soft atherosclerotic lesion in the rabbit aorta by an invasive IVUS method vs an non invasive MRI technology 206
Dysregulated expression of ankyrin repeat domain 1 in the developing myocardium causes anomalous venous return and morphogenetic defects by impairing cardiac remodelling 201
Hypocholesterolemic effect of the combination between vegetable proteins and fibres: impact on genes regulating cholesterol homeostasis 200
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL 199
Effect of lupin proteins on lipid-lipoprotein metabolism: in vitro and in vivo studies 191
Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System 187
HMGCoA reductase inhibitors: in vivo effects on carotid intimal thickening in normocholesterolemic rabbits 186
Nutraceutical alternatives to red yeast rice extract/monacolin K for moderate hypercholesterolaemia: Current evidence and knowledge gaps 183
Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I-Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques - In vivo assessment by intravascular ultrasound and magnetic resonance imaging 183
Bioactive components from Antartic krill exert anti-atherosclerotic activity in apoe-deficient mice 183
Effect of Dietary Components from Antarctic Krill on Atherosclerosis in apoE-Deficient Mice 182
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease 181
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return 178
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant 178
ApoA-I deletion in apoE-KO mice promotes massive cholesterol accumulation and inflammation in skin and skin-draining lymph nodes 178
A transgenic mouse model for the detection of cellular stress induced by toxic inorganic compounds 175
ApoA-I deficiency in apoe-ko mice severely alters lymph nodes and modulates T lymphocyte subsets 175
LACIDIPINE: IN VIVO EFFECTS ON INTIMAL CAROTID THICKENING IN HYPERCHOLESTEROLAEMIC RABBITS 174
HDL therapy for the treatment of cardiovascular diseases 172
Hepatocyte-specific PPAP2B ablation increases plasma levels of several minor pro-atherogenic lipid species and worsens atherosclerosis in apoE(-/-) MICE 169
Evaluation of nutritional and biological properties of a lupin protein isolate in sprague-dawley rats 168
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice : a clue to the disputed activity of statins on HDL 167
Impaired secretion of two apolipoprotein A-I mutants associated with hereditary amyloidosis 166
Hypolipidemic effect of dietary legume proteins: impact on genes regulating hepatic lipid metabolism 165
Acute effects of high-density lipoproteins : biochemical basis and clinical findings 163
Lack of transcriptional effects on apoA-I by Rosuvastatin in a transgenic mouse model 163
Sympathetic neurotransmission during atherosclerosis development: an unrecognized target of dyslipidemia? 160
Reference maps of mouse serum acute-phase proteins : changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes 159
Hypolipidemic effect of dietary pea proteins : impact on genes regulating hepatic lipid metabolism 159
Gene-expression profiling of lymph nodes reveals that apoa-i deficiency in apoe-ko mice induces a dramatic activation of the immune response 159
Effect of high cholesterol diet on cholesterol and bile acid metabolism in A-IM and A-I knock-in mice 157
The low plasma concentration of amyloidogenic apolipoprotein A-I can be explained by a reduced efficiencyof its cellular secretion 157
Skin morphology in double apoA-I/apoE knock-out mice : a structural and ultrastructural study 157
Topiramate protects ApoE-deficient mice from kidney damage without affecting plasma lipids 155
Lupin (Lupinus albus) protein isolate (L-ISO) has adequate nutritional value and reduces large intestinal weight in rats after restricted and ad libitum feeding 153
Increased cholesterol efflux potential of sera from ApoA-I-Milano carriers and transgenic mice 153
Anti-atherosclerotic activity of bioactive components from Antarctic krill in apoE-deficient mice 153
Sympathetic neurotransmission during atherosclerosis development: an unrecognized target of dyslipidemia? 153
Marine n-3 polyunsaturated fatty acids : Efficacy on inflammatory-based disorders 153
ApoA-I expression stimulates blood fibrinolytic activity in transgenic mice 152
Dietary supplementation with tetradecylthioacetic acid or salmon peptides reduces atherosclerosis progression in apoE-KO mice 149
Effects of fibers and gut microbiota on low-grade inflammatory human disease 149
Impact of different dietary treatments on the molecular lipid profile of aortic plaques in apolipoprotein e-null mice : an example of lipidomics potential for translational medicine 147
Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate 145
Biotechnology Approaches for the Treatment of Dyslipidemia 145
Atherosclerotic plaques investigation in apoE-/- mice using MRI and following administration of B22956/1 144
Impact of dietary treatments on the lipidomic profile of plasma, aorta and liver from ldlr-ko and pcsk9-ko mice 143
Role of human apolipoproteins in cell cholesterol efflux: Studies with transgenic mice 141
Apolipoprotein A-I and the molecular variant A-IM : evaluation of effects on atherosclerosis in a knock-in mouse model 140
Human apolipoproteins A-I and A-II in cell cholesterol efflux - Studies with transgenic mice 140
Effect of tetranectin-apo-A-I infusions on atherosclerosis progression/regression in hypercholesterolemic rabbits 139
Impaired secretion of two apolipoprotein A-I mutants associated with hereditary amyloidosis 138
Lupin proteins reduce progression of a focal atheromatous lesion in rabbits 136
Dose-related effects of repeated recombinant apoA-IMilano administrations on regression of plaques generated in rabbit carotid arteries 136
Hepatic miRNA expression profiling in genetically modified mouse models of different atherosclerosis susceptibility 136
Lupin proteins reduce progression of a focal atheromatous lesion in rabbits 135
Analysis of differentially expressed genes in livers of knock-in mouse models by microarray technology 135
Interazione tra innervazione arteriosa e dislipidemia nella patogenesi dell'aterosclerosi = Cross-talk between arterial innervation and dyslipidemia in the pathogenesis of atherosclerosis 135
Effect of homoarginine administration on neointimal thickening in balloon-injured rat carotid arteries 133
The Role of Marine n-3 Polyunsaturated Fatty Acids on Inflammatory-Based Disease: The Case of Rheumatoid Arthritis 133
Comparative lipidomic profiling of plasma and aorta from ldlr-KO, pcsk9-KO and C57bl/6 mice 131
Dose-related effects of repeated recombinant apoA-IMilano administrations on regression of plaques generated in rabbit carotid arteries 129
Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound 129
Apolipoprotein A-I and the molecular variant A-IM: evaluation of the antiatherogenic effect in a transgenic model 129
Rosuvastatin lacks transcriptional effects on ApoA-I in a transgenic mouse model 128
Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation 128
Acidi grassi poliinsaturi e rischio cardiovascolare 128
Impact of oil and proteins derived from Antarctic krill on atherosclerosis development in apoEKO mice 128
Homoarginine: a new potential avenue in the management of neointimal hyperplasia? 128
Effect of tetranectin-apoa-i infusions on atherosclerosis progression/regression in rabbit carotid arteries 127
Apolipoprotein A-I deficiency alters the small intestine transcriptome and increases the expression of the antimicrobial enzyme DUOX2 126
Totale 20.234
Categoria #
all - tutte 68.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20223.041 157 137 160 339 192 285 234 244 424 384 184 301
2022/20231.873 243 127 191 170 208 374 51 126 195 35 119 34
2023/20241.507 46 108 122 170 348 100 49 72 62 131 134 165
2024/20253.264 106 285 48 389 303 128 152 355 195 245 230 828
2025/20266.850 687 379 700 517 594 450 760 393 822 531 662 355
Totale 24.595